Latest Announcements

Krsnaa Diagnostics Ltd has announced its Q2 and H1 FY27 earnings, with revenue crossing INR500 crores for the first time. The company has achieved a 27% year-on-year growth, with a potential 37% growth had some contracts continued. The management team highlighted the company's ability to create new growth opportunities and its infrastructure, experience, technology, and trust earned over the years.

Ramky Infrastructure Ltd reported a 28% growth in Q2 FY27 consolidated revenue and a 36% increase in PAT. The company's consolidated revenue from operations for H1 FY27 increased 26.4% to ₹1,075.77 crore. The company's management commentary highlighted the continued focus on strengthening its position in the investor-operator model in industrial parks, water and wastewater, and urban infrastructure.

Ramky Infrastructure Limited has announced its unaudited financial results for the second quarter and half year ended September 30, 2026, with consolidated revenue from operations growing 28.2% to ₹604.54 crore and PAT increasing 35.9% to ₹102.81 crore.

Kirloskar Industries Ltd has announced its unaudited financial results for the quarter and half-year ended 30 September 2026. The company's income from continuing operations was ₹61.32 crore, with a net profit before tax of ₹53.84 crore. The company's total income was ₹62.43 crore, with a net profit after tax of ₹41.12 crore. The earnings per share for the quarter was ₹38.65.

Kirloskar Ferrous Industries Ltd announced its Q2 FY'27 earnings, with a topline growth of 16% and a bottom-line PBT growth of 15.5%. The company's pig iron production increased by 3% YoY, while casting production grew by 20%. The company's sales realizations improved due to the passing on of cost increases to customers, with pig iron prices increasing by 12.4% and casting prices increasing by 6.8%. The company's steel production grew by 48% YoY, while tube production declined by 2%. The company's management expressed optimism about the future, citing a gradual improvement in commodity prices and a potential advantage in basic products.

Brooks Laboratories Ltd has announced its financial results for the quarter and half year ended September 30, 2026. The company's revenue from operations was Rs. 1,924.79 lakhs for the quarter and Rs. 4,220.87 lakhs for the half year. The net profit after tax was Rs. 6,998.82 lakhs for the quarter and Rs. 7,140.68 lakhs for the half year.

Ramky Infrastructure Limited has informed the Exchange about Investor Presentation under regulation 30 of SEBI (LODR) Regulations, 2015, for the quarter ended 30th September 2026. The presentation highlights the company's financial performance, order book, and future plans.

Ramky Infrastructure Ltd has released its investor presentation for the quarter and half year ended September 30, 2026, highlighting its strong execution discipline, excellent margins, and a diversified order book. The company's CEO, Sunil Nair, expressed confidence in delivering on its medium-term growth and long-term profitable aspirations.

State Bank of India held an Analyst Meet following the announcement of its second quarter results. The Chairman, Mr. C.S. Setty, presented an overview of the bank's Q2 FY2027 performance and strategic initiatives undertaken during the period. The bank's financial results reflect the continued resilience of the Indian economy and the underlying strength of SBI's franchise.

Brooks Laboratories Ltd has announced its financial results for the quarter and half year ended September 30, 2026, with a net profit of ₹6,998.82 and ₹7,140.68, respectively. The company's revenue from operations was ₹1,924.79 lakhs and ₹2,296.08 lakhs for the quarter and half year, respectively.

Brooks Laboratories Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026. The company reported a net profit of ₹6,998.82 lakhs for the quarter and ₹7,140.68 lakhs for the half year. The results will be published in the newspapers in due course.

Jaro Education reported a robust H1 FY27 performance with a 21% YoY growth in PAT, 15% YoY growth in Total Income, and 12% YoY growth in EBITDA. The company also witnessed encouraging operational traction with learner volumes registering 7% YoY growth, Average Revenue Per User (ARPU) increasing 5%, and gross bookings growing 13% YoY.

Jaro Education reported robust H1 FY27 performance with 15% YoY growth in Total Income and 21% YoY growth in PAT. Revenue from operations increased 10% YoY to Rs. 8,774 lakh in Q2 FY27. EBITDA grew 7% YoY to Rs. 2,844 lakh, while PAT margin remained healthy at approximately 21% of Revenue from Operations.

Data Patterns (India) Limited has informed the Exchange about Investor Presentation for Q2 FY 2026-27, with a strong outlook and positioning across the portfolio, and a focus on delivering profitable growth and strong cash generation.

Data Patterns (India) Ltd has announced its investor presentation for Q2 FY 2026-27, highlighting its strong order inflow, revenue growth, and EBITDA margins. The company has received fresh orders worth Rs. 929 crore in Q2FY27, taking H1FY27 inflows to Rs. 1,858 crore. The company is confident on growing its existing product profile and expects additional revenue generation by tapping the larger market opportunities from new international customers.

Shelter Pharma Ltd has announced its un-audited financial results for the half year ended September 30, 2026, with revenue up 35.6% to Rs 451.3 million and PAT up 15.4% to Rs 51.9 million. The company's management has discussed its performance, highlighting growth in both human and animal health segments, with domestic sales and exports contributing to the revenue. The gross margin was 22.6%, lower than the previous year due to increased logistics costs. EBITDA rose 17.9% YoY and 14.2% HoH to Rs 73.8 million, with a margin of 16.4%, up 13 bps HoH and down 244 bps YoY.

Shelter Pharma Ltd announced its un-audited standalone financial results for the half year ended September 30, 2026, with revenue up 35.6% to Rs 451.3 million and PAT up 15.4% to Rs 51.9 million. The company reported a gross margin of 22.6%, 237 bps lower YoY and 57 bps lower HoH, due to increased logistics costs. EBITDA rose 17.9% YoY and 14.2% HoH to Rs 73.8 million.

Shringar House of Mangalsutra Ltd has released its Q2 & H1 FY27 earnings conference call transcript, highlighting a strong performance with healthy growth in revenue and profitability. The company has completed one year since its listing on the stock exchanges and has continued to focus on strengthening its business, building customer relationships, and creating a strong foundation for future growth.

Suprajit Engineering Limited has informed the Exchange regarding 'Press Release and Investors Presentation dated November 7, 2026'. The company's overall operating performance was solid, with consolidated revenue growing by 20.6% and EBITDA growing by 26.7% in the quarter. Revenue growth was exceptionally strong at 24.3% at GCM and 50.4% at SED. The company's Global Cables & Mechatronics Division (GCM) delivered strong operational numbers, with revenue growing by 24+% in both the quarter and the half year, and EBITDA growth at 69% for the quarter and 115.9% for the half year.

Shalby Ltd's Q2 FY 2027 earnings conference call transcript reveals a broad-based growth in the Hospitals business, with joint replacement continuing to grow and other specialties like nephrology and urology showing significant growth. The company is expanding its multispecialty network, adding specialist doctors, and improving operational efficiencies. The MedTech business is also expanding its robotic surgery capabilities in oncology and urology.